EPZICOM (abacavir sulfate; lamivudine) 600; 300 mg/1; mg/1 oral tablet, film coated

GSFC2 pill
Epzicom (abacavir 600 MG / lamivudine 300 MG) Oral Tablet
ViiV Healthcare Company

This orange, oval pill imprinted with GS FC2 is a Epzicom (abacavir 600 MG / lamivudine 300 MG) Oral Tablet, per the NIH.

EPZICOM is a human prescription drug. The active pharmaceutical ingredient is abacavir sulfate; lamivudine and is classified as, "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [Chemical/Ingredient], Nucleoside Reverse Transcriptase Inhibitors [MoA], Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [Chemical/Ingredient], Nucleoside Reverse Transcriptase Inhibitors [MoA]."

This pill is made by a total of 5 firms: (1) ViiV Healthcare Company, (2) Physicians Total Care, Inc., (3) GlaxoSmithKline LLC, (4) State of Florida DOH Central Pharmacy, and (5) REMEDYREPACK INC. .

Similar-looking pills

There are 3 other orange pills that with a similar imprint: "GS FC2". They may be a different dosage of the same drug or a different drug entirely.

GSI500 pill
12 HR ranolazine 500 MG Extended Release Tablet [Ranexa]
Orange, oval pill: "GSI500"
GSXJG pill
lapatinib 250 MG Oral Tablet [Tykerb]
Orange, oval pill: "GS XJG"
GSXJG pill
Tykerb 250 MG Oral Tablet
Orange, oval pill: "GS XJG"
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.